Send mail to Author

Long-term effects of ruxolitinib versus best available therapy on bone marrow fibrosis in patients with myelofibrosis (Article)

Please indicate your contact information and select, which author you want to contact.



 
  _  _    _    _     _  _    _    _    ______      ___    
 | \| || | || | ||  | \| || | || | || |      \\   / _ \\  
 |  ' || | || | ||  |  ' || | || | || |  --  //  | / \ || 
 | .  || | \\_/ ||  | .  || | \\_/ || |  --  \\  | \_/ || 
 |_|\_||  \____//   |_|\_||  \____//  |______//   \___//  
 `-` -`    `---`    `-` -`    `---`   `------`    `---`
 


Back to frontdoor view

OPUS4 Logo